FIELD: medicine.
SUBSTANCE: use of 2-(3,4-dihydroxyphenyl)-9-diethylaminoethylimidazo[1,2-a]benzimidazole(enoxifol) dihydrobromide as an agent for metastases inhibition is proposed.
EFFECT: reduced frequency of development and the number of metastases, with a level of toxicity similar to mexidol, more pronounced antimetastatic activity.
2 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG WITH ANTIPROLIFERATIVE AND ANTIMETASTATIC EFFECTS AGAINST LEWIS LUNG CARCINOMA WHEN INJECTED INTRAPERITONEALLY | 2022 |
|
RU2792144C1 |
| ANTI-TUMOUR AGENT AGAINST LUNG TUMOUR | 2021 |
|
RU2765472C1 |
| METHOD FOR ENHANCING ANTIMETASTATIC ACTION OF CISPLATIN AND REDUCING ITS SIDE EFFECT ON HAEMOSTASIS SYSTEM | 2023 |
|
RU2825825C1 |
| METHOD FOR ACHIEVING ANTIMETASTATIC EFFECT IN EXPERIMENT | 2017 |
|
RU2661704C1 |
| MEANS FOR INHIBITING METASTASIS IN THE LUNGS | 2021 |
|
RU2762730C1 |
| PULMONARY METASTASIS INHIBITOR | 2021 |
|
RU2765955C1 |
| METHOD FOR MURINE MELANOMA LYMPHATIC AND HEMATOGENOUS METASTASIS B SIMULATION FOR NONLINEAR WHITE RATS | 2016 |
|
RU2615908C1 |
| METHOD FOR SUPPRESSING THE GROWTH OF B16 MELANOMA IN LABORATORY ANIMALS | 2022 |
|
RU2784443C2 |
| METHOD OF THE MELANOMA B MALIGNANT GROWTH IN MICE MODIFICATION WITH CHRONIC PAIN | 2017 |
|
RU2650587C1 |
| BACILLUS SUBTILIS-BASED LYOPHILISATE FOR ANTI-TUMOUR IMMUNITY REPROGRAMMING | 2023 |
|
RU2821073C1 |
